Metabolic Health · Digestive System

Digestive system: cell therapy for intestinal conditions.

Persistent discomfort after eating, recurring inflammation or increased digestive sensitivity may be related to changes in the lining of the stomach or intestine. At LYRACELL we assess the origin and extent of the problem to determine whether cell therapy can be part of a personalized treatment.

Personalized cell therapyIntravenous applicationMinimally invasiveIn-house laboratory

Persona con malestar digestivo persistente, tratamiento celular en LYRACELL

Understanding the digestive system

The digestive system is involved in processing food and absorbing nutrients, but it also acts as a barrier and provides immune protection.

In certain chronic inflammatory or degenerative conditions, the gastric and intestinal lining can gradually deteriorate, affecting both its structure and its ability to perform these functions.

Chronic inflammation and epithelial deterioration

Persistent exposure to factors that damage the lining can impair its natural ability to repair itself and lead to lesions appearing or persisting.

Tissue damage and impaired function

During digestion, the functional demands on the system increase. When the tissues are affected, symptoms such as pain, heartburn, heaviness or discomfort after eating may appear.

Loss of intestinal barrier integrity

Deterioration of the lining can affect its protective function and be associated with changes in permeability, atrophy and a reduced ability to repair erosions or ulcers.

These processes can occur at the same time. That is why it is necessary to identify both the degree of involvement and its cause before defining the approach.

Médico de LYRACELL palpando el abdomen de un paciente durante la evaluación del sistema digestivo

How can it present?

Discomfort after eating

Discomfort may appear or worsen during or after meals.

Digestive pain or sensitivity

The stomach or intestine may become more sensitive due to the involvement of their tissues.

Heartburn

Changes in the gastric lining may come with burning or a feeling of acidity.

Heaviness

Digestion may cause a persistent feeling of bloating or heaviness.

Recurring symptoms

When there is a chronic process, symptoms may persist or return and start to affect eating and everyday activities.

Cell treatment

Your own cells, directed toward the tissues of the digestive system.

The body has natural mechanisms to repair the lining and modulate inflammation. However, in the face of chronic inflammatory diseases, aging or certain previous surgeries, that capacity may be insufficient.

In these cases, the contribution of cells aims to support biological processes related to the repair and remodeling of digestive tissues, modulate inflammation and support the recovery of the lining.

The personalized treatment combines two key components:

  • Mesenchymal stem cells: part of a preparation intended to support biological processes related to the remodeling of digestive tissue and the formation of new blood vessels.
  • Immune system cells: help direct the cell preparation and support its interaction with the affected tissues and the inflammatory environment.

Under the protocols of the Moviglia Method, the LYRACELL team obtains stem cells from the patient’s own adipose tissue and immune system cells from their blood. The cells are processed in the laboratory and combined as part of a preparation directed toward the structures of the digestive tract.

The preparation is administered intravenously, with the aim of supporting processes linked to the repair of the lining, the modulation of inflammation and digestive function.

The combination of both cell types aims to support the body’s natural repair process, through a personalized approach and under strict safety protocols.

Preparación de terapia celular orientada al tejido digestivo

From the laboratory to the digestive system

The stem cells are obtained from the patient and, together with the immune system cells, are processed in the laboratory following the protocols of the Moviglia Method. Based on the diagnosis and the type of involvement identified, the LYRACELL team prepares a specific cell combination before its administration.

Obtención de células madre del tejido adiposo y células del sistema inmune de la sangre
Cell collection
Mesenchymal stem cells are obtained from adipose tissue through a mini-liposuction, and immune system cells are obtained from a peripheral blood sample from the patient or, depending on the medical indication, from a selected donor, without modifying their genome.
Procesamiento celular en LYRACELL Lab, laboratorio propio de LYRACELL
Laboratory processing
The cells are selected, expanded and processed at LYRACELL Lab, LYRACELL’s in-house laboratory, following the criteria of the Moviglia Method, with quality protocols and full traceability at every stage.
Preparación de terapia celular específica orientada al tejido identificado en el diagnóstico
Targeted therapy
The preparation is directed to the structures of the digestive tract identified during diagnosis, with stem cells and immune system cells that aim to support the repair of the lining and modulate inflammation.
Icono de aplicación dirigida de terapia celular por vía intravenosa en el sistema digestivo
Targeted application
The preparation of stem cells and specific immune system cells is administered intravenously, with the number and frequency defined according to the degree of digestive involvement in each case.
How the treatment works

Four stages, an approach defined by the origin of the damage.

From identifying what is affecting the lining to monitoring its progress, each stage is defined according to the characteristics of each case.

Consulta médica de evaluación digestiva con estudios endoscópicos

1

Evaluation

The medical history, digestive background, how long the symptoms have been present and any available additional studies are reviewed. This may include clinical, laboratory and endoscopic studies to determine the degree of tissue involvement, the extent of the damage and its possible origin.

Preparación en laboratorio de la combinación celular personalizada para el sistema digestivo

2

Treatment proposal

The medical team determines whether cell therapy may be appropriate. If the patient is eligible, adipose tissue and peripheral blood are collected, and a cell combination adapted to the identified tissue involvement is prepared in the laboratory.

Aplicación de terapia celular por vía intravenosa en LYRACELL

3

Application

The cell preparation is administered intravenously. The number and frequency of applications are determined individually according to the degree of involvement and the clinical progress observed.

Consulta de seguimiento y control de la evolución digestiva tras el tratamiento

4

Follow-up

Follow-up assesses the course of the symptoms and the digestive involvement. It may be complemented with an adapted nutrition plan, microbiota management and control of risk factors, as medically indicated, to support tissue recovery.

An accurate evaluation makes it possible to treat the specific problem, not just the symptom.

Who it is for

Could this treatment be an option for you?

The indication is defined individually based on the diagnosis, the origin of the symptoms and the presence of involvement of the lining or digestive tissues that can be demonstrated through the corresponding studies.

It may be an option if…

You have chronic gastritis with persistent involvement of the lining.

There is a diagnosis of atrophic gastritis.

You have gastric ulcers that require assessing the condition and repair capacity of the tissue.

Changes in intestinal permeability have been identified.

You have a selected inflammatory disease for which the medical team considers that cell therapy may be part of the approach.

Digestive symptoms persist and there is measurable tissue involvement.

You want to preserve the integrity and function of the lining in the face of identified chronic digestive damage.

Another approach may be needed if…

There is an acute digestive complication that requires immediate care.

You have massive active bleeding or a digestive perforation that requires emergency medical or surgical treatment.

There is an untreated acute infection that must be addressed before considering cell therapy.

There is a severe autoimmune process in a critical phase that requires another type of medical intervention.

The indication is defined individually based on the medical evaluation and the corresponding studies.

Recovery is also part of the treatment

Treating the tissue is part of the process. Caring for its environment is too.

After the application, the medical team defines a follow-up plan adapted to the diagnosis, the degree of involvement and each patient’s progress.

First days

The medical team carries out follow-up after the administration and sets the necessary guidelines for each case.

Nutrition, microbiota and risk factors

Diet and the intestinal environment are part of the approach. An adapted nutrition plan, microbiota management and control of risk factors can complement cell treatment as medically indicated. The goal is to support the conditions needed for recovery and prevent factors that could continue to affect the lining from persisting.

Measurable results

Follow-up makes it possible to assess the course of symptoms and the clinical response over time. When indicated, laboratory or endoscopic studies can be repeated to compare the condition of the tissues with the starting point.

Frequently asked questions

In addition to taking part in digestion and absorption, the lining acts as a protective and immune barrier between the body and the contents of the digestive tract.

Chronic inflammatory processes, aging and certain previous surgeries can compromise the lining’s natural ability to repair itself. The cause must be identified during the evaluation.

The evaluation considers the medical history and digestive background and may be complemented with laboratory and endoscopic studies to analyze the extent and characteristics of the damage.

The base treatment is autologous: the stem cells are obtained from the patient’s own adipose tissue and the immune system cells from their blood. In certain cases, depending on the medical indication, immune system cells from a selected donor may be used.

The preparation of stem cells and specific immune system cells is administered intravenously.

The number of applications is defined at the start of treatment, according to the degree of involvement, as part of a plan with specific goals. At the end of the plan, progress is assessed and, if needed, further interventions are defined.

No. The nutrition plan, microbiota management and control of risk factors can complement cell treatment and be part of the comprehensive approach.

Certain inflammatory diseases can be evaluated by the medical team. Eligibility depends on the diagnosis, the phase of the disease, the degree of tissue involvement and each patient’s general condition.

Not when there is a digestive emergency. Massive active bleeding, a perforation or another acute complication requires immediate medical or surgical care.

The first step is understanding what is affecting your digestive system.

Every treatment begins with a medical evaluation to identify the origin of the symptoms, understand the condition of the lining and determine which approach may be right for you.